



Persistent allergic rhinitis and bronchial asthma 
are the two main clinical manifestations of chronic 
atopy of the respiratory tract. The upper and lower 
airways cannot be separated from each other and 
can be treated with different immunomodulatory ap-
proaches, such as allergen-specific immunotherapy, 
as well as drugs that affect both compartments of the 
respiratory tract. Type II inflammation due to the 
Th2-controlled response to allergens in rhinitis and 
asthma is common, although these atopic conditions 
are characterized by some heterogeneity [1].
There are three aspects of heterogeneity: pheno-
type, endotype and biomarkers.
Phenotype is a classification category, which 
is determined by genotype, hereditary epigenetic 
factors and environmental factors. An endotype is 
a classification that is defined by various cellular 
and molecular pathways that underlie functional or 
pathobiological mechanisms. Endotypes include such 
features as clinical and immunological characteris-
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tics, histopathology, upper and lower physiology, 
and the response to therapy for allergic rhinitis and 
asthma. Biological markers are specific parameters 
attributed to both phenotypes and endotypes [2–4].
A cohort of atopic patients of both sexes was 
studied in order to identify different endotypes and 
differentiate different therapeutic approaches associ-
ated with antigen-specific therapy and topical gluco-
corticoids. All patients (n = 61), aged 18 to 60 years, 
suffered from persistent allergic rhinitis that was ac-
companied by mild to moderate asthma, and 21 of 
them had food allergies to the most common aller-
gens in adults, such as cow’s milk, shrimp, peanuts, 
chicken eggs and wheat flour. Twenty healthy vol-
unteers of the same age served as a control group.
A study of the case, family, social and occupa-
tional histories, questionnaire NHANES [5], physical 
and functional airway examination, serum polyspe-
cific and allergenspecific IgE to Dermatophagoides 
pteronissinus (Der p 1), common major food aller-
gens (nBos d 4, rPen a 1, nAra h 2, nGal d 2, and 
rTri a 19), IL4, IFNg, IL10, and allergic skin tests 
were carried out.
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The “cluster” analysis enabled dividing the pa-
tients into four groups, or endotypes (see Table).
T a b l e 
Endotypes of atopic conditions
Entity Endotype n
1








Classical atopic endotype with no food 
allergy
10
4 Entopic endotype [6] 15
The correlation analysis for the whole co-
hort demonstrated the close correlation (r = 0.88, 
p < 0.002) between serum IgE to Dermatophagoides 
pteronissinus (Der p1) and concentration of IL4 that 
confirmed atopic nature of all aspects of the investi-
gated cases (see Fig.).
It was established that the classical atopic endo-
types were in total characterized by high serum con-
centration of polyspecific IgE, general Th2 polariza-
tion, the frequency of positive allergy skin tests, and 
atopic family heredity. The classical atopic endotype 
with subclinical food sensitization was differentiated 
by the high level of oral tolerance due to many de-
scribed mechanisms [7].
Interestingly, the food sensitization in patients of 
this endotype was the same as in patients of the 
other classical atopic endotype with clinical signs of 
food allergy.
The absence of sensitization to food proteins and, 
correspondingly, food allergy symptoms may be 
linked to the high, well-controlled, oral tolerance [8].
Figure. Correlation between serum IgE to dust mites and IL4
Entopy or entopic endotype is a new phenome-
non discovered in allergology and immunology sev-
eral years ago [6]. As our investigations showed, 
almost all parameters were the same as in healthy 
persons, and there are no systemic allergy signs. 
Nowadays, clinicians such as ENT specialists and 
lung physicians are involved in a discussion relat-
ed to the diagnosis, treatment, and the relationship 
between local allergy and conventional or systemic 
allergy. Currently, the term “local rhinitis” is widely 
used, whereas there are only two references to “lo-
cal asthma” [9, 10].  However, a positive response 
to omalizumab in “non-allergic” severe asthma was 
described [11, 12] that demonstrated the presence 
of atopic IgE-dependent inflammation in such pa-
tients.
Atopic conditions are characterized by hetero-
geneity and may accompany the covert or clinical 
food sensitization, which enables downregulating the 
course of any atopic disease. The identification of 
atopic endotypes will promote and drive innovative 
developments in both allergen-specific immunother-
apy and anti-inflammatory approaches, including 
severe asthma.
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